FTLF — FitLife Brands, Inc.
NASDAQ
Q1 2026 Earnings Call Summary
May 14, 2026
FitLife Brands (FTLF) Q1 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Total Revenue: $25.3 million, up 59% year-over-year, primarily due to the acquisition of Irwin.
- Wholesale Revenue: $14.1 million (56% of total revenue), a 166% increase year-over-year.
- Online Revenue: $11.2 million (44% of total revenue), a 6% increase year-over-year.
- Gross Margin: 37.6%, down from 43.1% in Q1 2025, attributed to Irwin's lower historical margins.
- Net Income: $1.7 million, down from $2.0 million in Q1 2025, mainly due to higher amortization and interest expenses.
- Adjusted EBITDA: $3.3 million, a 3% decrease year-over-year.
- Legacy FitLife Performance: Revenue down 22% year-over-year, with significant declines in both wholesale and online sales.
2. Strategic Updates and Business Highlights
- Irwin Performance: Generated $12.8 million in revenue, with 80% from wholesale. Amazon sales increased from $500,000 in December 2025 to approximately $800,000 in March 2026.
- Product Launches: Introduction of two MusclePharm SKUs in Kroger stores, expected to reach 700-800 locations starting in June.
- Advertising Strategy: Increased investment in off-Amazon advertising, with a focus on driving traffic to Amazon listings.
- Inventory Management: Progress in reducing inventory obsolescence through the introduction of products with extended dating.
3. Forward Guidance and Outlook
- Revenue Trends: Sequential revenue improvement noted in April, with expectations for continued growth in Irwin's Amazon business and overall revenue stability.
- Indebtedness Management: Plans to use excess free cash flow to reduce debt further, with a current term loan balance of $37.6 million.
- New Product Listings: Anticipation of launching additional products on Amazon Canada in Q2 2026.
4. Bad News, Challenges, or Points of Concern
- Declining Metrics: Legacy FitLife's revenue and contribution margins are down significantly, with ongoing challenges in wholesale and online sales.
- Gross Margin Pressure: The decline in gross margin due to the acquisition of Irwin and ongoing out-of-stock issues affecting revenue.
- Out-of-Stock Issues: Significant revenue loss attributed to stock shortages, particularly affecting high-selling products.
- Competitive Pressures: Challenges from price-sensitive international customers impacting MusclePharm's revenue and margin strategy.
5. Notable Q&A Insights
- Revenue Trends: CEO Dayton Judd highlighted sequential improvement in monthly revenue, with April being the strongest sales month of the year.
- Irwin Growth Potential: Judd expressed confidence in reaching at least $1 million in monthly revenue for Irwin, driven by new product listings and improved stock availability.
- MusclePharm Strategy: Revenue decline was by choice, focusing on higher-margin sales rather than competing aggressively on price with international customers.
- Advertising Focus: Shift towards off-Amazon advertising strategies is seen as essential for future growth, with a multi-month process to address past performance issues on Amazon.
Overall, while FitLife Brands has shown strong growth from the Irwin acquisition, challenges remain with Legacy FitLife's performance and margin pressures. The company is optimistic about future growth driven by strategic initiatives and improved inventory management.
